TB 500 5 mg
$27.00
Axiolabs TB 500 5 mg – Thymosin Beta-4 for Tissue Repair Research
Axiolabs TB 500 5 mg is a synthetic version of Thymosin Beta-4, a naturally occurring peptide involved in wound healing, cell migration, and inflammation modulation. Each 2 mL vial contains 5 mg of lyophilized TB-500, ready for reconstitution for research applications involving soft tissue repair, angiogenesis, and recovery processes.
TB-500 has gained recognition in research circles for its ability to promote actin regulation, cell proliferation, and blood vessel formation. Unlike traditional growth factors, TB-500 works through multiple pathways including upregulation of matrix metalloproteinases and anti-apoptotic mechanisms. Explore similar research compounds like BPC 157 5 mg or GHK-CU 50 mg.
What Makes Axiolabs TB 500 Unique?
TB-500's primary mechanism involves binding to actin, a key structural protein in cells, which facilitates cell migration, proliferation, and differentiation. This actin-sequestering property distinguishes TB-500 from most other repair-focused peptides and underlies its effects on wound closure, scar reduction, and tissue remodeling.
For researchers investigating recovery acceleration, TB-500 is often studied alongside BPC-157 for synergistic effects on soft tissue repair. The 5 mg dosage and extended half-life make it suitable for twice-weekly administration protocols. Researchers may also combine TB-500 with BPC 157 to evaluate comprehensive tissue regeneration models.
Benefits of Axiolabs TB 500 for Research
- ✔ Supports wound healing and tissue repair research
- ✔ Promotes angiogenesis and cell migration studies
- ✔ 5 mg lyophilized powder for flexible dosing
- ✔ Suitable for subcutaneous administration research
- ✔ Can be stacked with BPC-157 for comprehensive repair protocols
Axiolabs TB 500 5 mg is intended for laboratory research only. Not for human consumption or clinical use.
External research on TB-500's mechanisms can be explored via PubMed for peer-reviewed studies.